Moreover, EBV-associated GC cells are treated with JAK2 inhibitor, PI3K inhibitor, and mTOR inhibitor, which arrests G0/G1, promotes the proliferation of T cells, and reduces the PD-L1 expression (158). This evidence concerns the gene PIK3CG and gastric cancer.